Freestone Grove Partners LP Penumbra Inc Transaction History
Freestone Grove Partners LP
- $9.71 Trillion
- Q1 2025
A detailed history of Freestone Grove Partners LP transactions in Penumbra Inc stock. As of the latest transaction made, Freestone Grove Partners LP holds 49,422 shares of PEN stock, worth $13.4 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
49,422Holding current value
$13.4 Million% of portfolio
0.14%Shares
1 transactions
Others Institutions Holding PEN
# of Institutions
476Shares Held
29.1MCall Options Held
346KPut Options Held
62.3K-
Black Rock Inc. New York, NY4.26MShares$1.15 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.68MShares$994 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.21MShares$327 Million0.04% of portfolio
-
State Street Corp Boston, MA1.2MShares$324 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT870KShares$235 Million1.79% of portfolio
About Penumbra Inc
- Ticker PEN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,888,400
- Market Cap $10.2B
- Description
- Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...